Left for dead after a failure in neuropathic pain, Aptinyx latches onto positive PhII data in PTSD
Almost two years after a Phase II fail sent investors running for the hills, Aptinyx $APTX may have found a new lifeline.
The Evanston, IL …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
